Potential antitumor agents. V. Bisquaternary salts.
D000818:Animals; D002625:Chemistry, Organic; D005260:Female; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D055601:Organic Chemistry Phenomena; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000188:drug therapy
D006571:Heterocyclic Compounds; D000644:Quaternary Ammonium Compounds